¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ¸ð°ø°¢È­Áõ ½ÃÈï ±¸¿ùµ¿ Ä¡·á Ãʱ⿡ °ü¸®ÇØ¿ä

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#¼Ûµµ¸ð°ø°¢È­Áõ, #¼Ûµµ¸ð°ø°¢È­ÁõÄ¡·á, #ÇǺο°, #¼ÛµµÇǺο°, #¸ð°ø°¢È­ÁõÄ¡·á, #ÇǺο°Ä¡·á, #¼ÛµµÇǺο°, #¼Ûµµ¸ð°ø°¢È­Áõ ¼Ûµµ¸ð°ø°¢È­Áõ,,¼Ûµµ¸ð°ø°¢È­ÁõÄ¡·á,,ÇǺο°,,¼ÛµµÇǺο°,,¸ð°ø°¢È­ÁõÄ¡·á,,ÇǺο°Ä¡·á,,¼ÛµµÇǺο°,,¼Ûµµ¸ð°ø°¢È­Áõ ¾È³çÇϼ¼¿ä. ¼Ûµµ¸ð°ø°¢È­Áõ ¼Ûµµ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ¼Ûµµ¸ð°ø°¢È­Áõ ¼Ûµµ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÇǺο°, ¼Õ¾ÆÅäÇÇ, Àӽŵε巯±â, È­Æó½ÀÁø, Äݸ°¼ºµÎµå·¯±â, ¸ñ¾ÆÅäÇÇ, »ç¸¶±Í, ¾ó±¼È«Á¶, ¾È¸éÈ«Á¶Áõ, ÆÇ»ó°Ç¼±, ¾ó±¼»ç¸¶±Í, Å¿­, ¼Õ°¡¶ô»ç¸¶±Í, µî°Ç¼±, Áö·ç¼ºÇǺο°Ä¡·á, ¾î¸°À̻縶±Í, ¾Æ±â¾ÆÅäÇÇÇǺο°, ¾ÆÅäÇÇÄ¡·á, ¿øÇüÅ»¸ð, ¹ß»ç¸¶±Í, ¾î¸°¼±, ³óÆ÷¼º°Ç¼±, »çŸ±¸´Ï½ÀÁø, °æÇÇÁõ, ¿©¸§¾ÆÅäÇÇµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ¼öÄ¡·á, ³ì¿ë, °ñµµ¹ý°Ë»ç, °æ±ÙÃß³ª¿ä¹ý, ¿µ¾ç±³À°, paraffin, ÇѹæÁ¤½Å¿ä¹ý, °æ¶ôÇâ±â¿ä¹ý, ½½¸µ, ÀιٵðÃøÁ¤, ±¤¿ªµ¿¿ä¹ý, ¼ºÀåÀڱؿä¹ý, ¾È¸éÁ¤Çüħ¼ú, manipulation, ü¿­Áø´Ü(Àü½Å), ºñ¸¸Àüħ, ÀüÀÚ¿ä¹ý, Ȳ·ÃÇص¶ÅÁ¾àħ, ¾óÀ½¿åÁ¶, ü¼ººÐºÐ¼®, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç °æ³² ±èÇؽà »ï°èµ¿, °æ³² â¿ø½Ã ¸¶»êȸ¿ø±¸ ÇÕ¼º1µ¿, ÀüºÏ ÀÍ»ê½Ã Çö¿µµ¿, ÀüºÏ ÀÍ»ê½Ã ¿ëÁ¦µ¿, °æºÏ ¿µÁֽà ¾ÆÁöµ¿, °æ³² ¾ç»ê½Ã »ïÈ£µ¿, Ãæ³² ¿¹»ê±º ½Å¾Ï¸é, Àü³² ¿µ±¤±º ¿°»ê¸é, °æºÏ ºÀÈ­±º ¼Òõ¸é, ÀÎõ µ¿±¸ ⿵µ¿, ºÎ»ê ¼­±¸ ¾Æ¹Ìµ¿2°¡, °æ±â ¾È¼º½Ã »ç°îµ¿, °æ³² â¿ø½Ã ÁøÇر¸ ¿¬µµµ¿, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ ´Ù°¡µ¿1°¡, °æ³² ¹Ð¾ç½Ã Ãʵ¿¸é, ÃæºÏ ÃæÁֽà ³ëÀº¸é, Àü³² ¸ñÆ÷½Ã ±¤µ¿3°¡, ¿ï»ê ºÏ±¸ ¸íÃ̵¿, °æ±â È­¼º½Ã ±â»êµ¿, ÀüºÏ ¹«ÁÖ±º Àû»ó¸é, ÀüºÏ ±º»ê½Ã ¿Á¼­¸é, °æ±â ¿ëÀνà ¼öÁö±¸ »óÇö2µ¿, ÀÎõ ³²±¸ ÁÖ¾È7µ¿, ºÎ»ê ±ÝÁ¤±¸ ºÎ°î4µ¿, ºÎ»ê Áß±¸ µ¿±¤µ¿3°¡, ÃæºÏ Á¦Ãµ½Ã ÀǸ²µ¿, ÃæºÏ ±«»ê±º ûõ¸é, °æ±â ºÎõ½Ã ¿ø¹Ì±¸ »ó2µ¿, ÀüºÏ Á¤À¾½Ã ½ÅÅÂÀÎÀ¾, ÀüºÏ ±º»ê½Ã ȸÇö¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ¼Ûµµ¸ð°ø°¢È­ÁõÄ¡·á ãÀ¸½Ã´Â °è»êµ¿, ÀÎõ¼­±¸, »óµ¿, ÇÐÀ͵¿, ¿ëÇöµ¿, Á־ȵ¿, ¿µÈïµµ, ½ÃÈ­, ¸¸¼öµ¿, ÀÎõ³íÇö, µ¿ÀÎõ, °Ë¾Ï, ¹è°ð½Åµµ½Ã, ´ëºÎµµ, ¿Á·Ãµ¿, ¼Û¸²µ¿, ÀÛÀüµ¿, ÀÎõ, ³²µ¿±¸, ¿ëÀ¯µµ, µ¿Ãᵿ, µ¿±¸, ºñºÀ¸é, ¼Ûµµ, µµ¸²µ¿, °¡Á¤µ¿, ¿¬¼ö±¸, Áßµ¿, ÀÎõÁÖ¾È, ¿¬¼öµ¿, ¹è°ð, ¼Û»ê¸é, ¿¬Èñµ¿, °Ë´Ü, ¼Ò·¡Æ÷±¸ µî ¼Ûµµ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Galli E, Chini L, Nardi S, et al. Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis. Allergol Immunopathol (Madr) 1994; 22:18. 2. Papp KA, Bissonnette R, Gooderham M, et al. Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial. BMC Dermatol 2016; 16:15. 3. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 2014; 71:116. 4. Saleem MD, Oussedik E, D'Amber V, Feldman SR. Interleukin-31 Pathway and its Role in Atopic Dermatitis: A Systematic Review. J Dermatolog Treat 2017; :1. 5. Eschler DC, Klein PA. An evidence-based review of the efficacy of topical antihistamines in the relief of pruritus. J Drugs Dermatol 2010; 9:992. 6. Hanania NA, Korenblat P, Chapman KR, et al. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med 2016; 4:781. 7. Bleehen SS, Chu AC, Hamann I, et al. Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment. Br J Dermatol 1995; 133:592. 8. Michail SK, Stolfi A, Johnson T, Onady GM. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2008; 101:508. 9. Panduru M, Panduru NM, Sălăvăstru CM, Tiplica GS. Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies. J Eur Acad Dermatol Venereol 2015; 29:232. 10. Novak N, Bieber T, Hoffmann M, et al. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol 2012; 130:925.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ¸ð°ø°¢È­Áõ ½ÃÈï ±¸¿ùµ¿ Ä¡·á Ãʱ⿡ °ü¸®ÇØ¿ä""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõºñ¿° ±¸¿ùµ¿ ½ÃÈï Ä¡·á ¸¶À½¿¡ ½ïµå´Â
´ÙÀ½±Û ÀÎõÁö·ç¼ºÇǺο° ±¸¿ùµ¿ ½ÃÈï ÇÑÀÇ¿ø ÇѹæÀÌ ÁÁ¾Æ
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
952 ´ÙÀ̾îÆ®ÇÑÀÇ¿ø »õÇØ À̺¥Æ® ÁøÇà ´ÙÀ̾îÆ®ÇÑ¾à ±¸ÀÔ Æ÷ÀÎÆ® Á¦°ø 0 69 2024-01-15
951 ÀÌõ±³Åë»ç°íÇÑÀÇ¿ø Ãʱ⠰ü¸®·Î ÈÄÀ¯Áõ ¿¹¹æÇØ¿ä 3 284 2023-10-14
950 ÆíµÎÅë ¿¹¹æ¾à ó¹æ, ÁøÅëÁ¦¿Í ÇѾà Ä¡·á ¾Ë¾Æº¸±â 0 290 2023-10-13
949 ¸Þ´Ï¿¡¸£º´ Áø´Ü ¹Þ¾Ò´Ù¸é ¾çÀç µÎûÇÑÀÇ¿øÀ¸·Î 0 315 2023-10-13
948 »êº»±³Åë»ç°íÇÑÀÇ¿ø Ä¡·á¸¸Á·µµ ³ôÀº ÀÌÀ¯ 0 480 2023-08-18
947 â¿ø ÇѾàÀßÁþ´Â°÷ À¯¾Ø¹ÌÇÑÀÇ¿ø 2 786 2023-06-02
946 [ÆíµÎÅëÄ®·³2ź]µÎûÇÑÀÇ¿ø, ÆíµÎÅëÀÌ Ä¡·á°¡ ¾ÈµÇ´Â ÀÌÀ¯ 0 617 2023-05-23
945 [ÆíµÎÅëÄ®·³1ź]µÎûÇÑÀÇ¿ø, ÆíµÎÅëÀ» ¾Î´ø ÇÑÀÇ»ç ÆíµÎÅëÀ» ¿ÏÄ¡ÇÏ´Ù 3 651 2023-05-19
944 â¿ø ¸¶»ê ´ß»ìÇǺΠ¸ð°ø°¢È­Áõ ÇÑÀÇ¿ø Ä¡·á·Î ½Î¾Ç~ 2 633 2023-05-11
943 ºÎ»ê¼­¸é´ÙÀ̾îÆ®ÇÑÀÇ¿ø »ýÈ°°Ç°­ÇÑÀÇ¿ø 5¿ù °¡Á¤ÀÇ´Þ Æ¯°¡À̺¥Æ® ½ÃÀÛ.. 3 853 2023-05-10
942 ±¸¿ùµ¿ÇÑÀÇ¿ø °æÈñÀÚ¶õÇÑÀÇ¿ø¿¡¼­ ´ÙÀ̾îÆ® ±³Åë»ç°í Ãß³ª¿ä¹ý ÀÎõ ³².. 2 768 2023-05-10
941 â¿ø´ÙÀ̾îÆ®ÇÑÀÇ¿ø, â¿ø´ÙÀ̾îƮȯ À¯¾Ø¹ÌÇÑÀÇ¿ø ½½¸²È¯ 2 773 2023-04-20
940 ûÁÖ º¹´ëµ¿ ÇÑÀÇ¿ø, ¸¶À½¿¡²ÉÇÑÀÇ¿ø º½¸ÂÀÌ À̺¥Æ® 18 850 2023-04-19
939 ¿µµîÆ÷ÇÑÀÇ¿ø ¼±ÇÑÀÇ¿ø Áñ°Å¿ö º½ À̺¥Æ® 14 755 2023-04-19
938 â¿ø ¸¶»ê ´ÙÀ̾îƮȯ À¯¾Ø¹ÌÇÑÀÇ¿ø 12 1,165 2023-03-20
937 â¿ø ¸¶»ê»êÈĺ¸¾à Çѹ泻°úÀü¹®ÀÇ °Ç°­ÇÑ È¸º¹ 14 963 2023-02-02
936 [¶óÀ²ÇÑÀÇ¿ø] º½À» ±â´Ù¸®´Â 2¿ù À̺¥Æ® 0 1,117 2023-02-02
935 ÇØ¿ÂÇÑÀÇ¿ø ¼³³¯À̺¥Æ® °øÁø´Ü °æ¿Á°í ½ÖÈ­ÅÁ ÇýÅà (~1/31) 1 886 2023-01-10
934 ÇÏÀÌÅ°ÇÑÀÇ¿ø 1¿ù À̺¥Æ® ¾È³» 0 1,032 2023-01-03
933 ¸¶ÀÌÇÃÇÑÀÇ¿ø ¿¬¸» °¨»ç À̺¥Æ® 0 1,385 2022-12-09
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷